Tango Therapeutics TNGX
NASDAQ TNGX
$23.24 -1.21 (-4.95%)
At close: Oct 2, 2026 · 4:00 PM EDT

Tango Therapeutics (TNGX) Depreciation & Amortization (CF) (2020 - 2026)

Updated

Tango Therapeutics (TNGX) recorded Depreciation & Amortization (CF) of $400,000 in Q2 2026, down 36.0% from $625,000 a year earlier and down 20.0% from the prior quarter.

Analysis

Tango Therapeutics (TNGX) Depreciation & Amortization (CF) (2020 - 2026) Analysis & Trends

On a TTM basis, Tango Therapeutics' Depreciation & Amortization (CF) came in at $1.95 million as of Jun 30, 2026, down 20.2% year-over-year; for FY2025, it came in at $2.3 million, down 8.0% from FY2024.

  • Annual Depreciation & Amortization (CF) has a five-year compound annual growth rate of 26.2% (FY2020 to FY2025).
  • Across earlier years, Depreciation & Amortization (CF) came in at $2.5 million in FY2024 (+3.5%), $2.42 million in FY2023 (+50.2%), $1.61 million in FY2022 (+78.7%) and $900,000 in FY2021 (+25.3%).
  • The Q2 2026 figure is the lowest quarterly Depreciation & Amortization (CF) since Q2 2022.
  • On a year-over-year basis, Depreciation & Amortization (CF) has declined for seven consecutive quarters, with an average decline of 11.3% over the last eight quarters.
  • Peak year-over-year performance for Depreciation & Amortization (CF) in the last five years was growth of 120.1% in Q4 2022, against a decline of 36.0% in Q2 2026 at the low end.
  • Per Business Quant, the preceding three quarters came in at $500,000 (Q1 2026), $498,000 (Q4 2025) and $555,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Amort. (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn 534.00 Mn
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn 1.96 Bn
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn 194.00 Mn
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn 599.00 Mn
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn -
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn 1.93 Bn
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn 1.11 Bn
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn 98.00 Mn
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn 1.62 Bn
10 Tango Therapeutics 4.12 Bn 2.23 Bn - 400,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 400,000.00
Mar 31, 2026 500,000.00
Dec 31, 2025 498,000.00
Sep 30, 2025 555,000.00
Jun 30, 2025 625,000.00
Mar 31, 2025 622,000.00
Dec 31, 2024 600,000.00
Sep 30, 2024 600,000.00
Jun 30, 2024 675,000.00
Mar 31, 2024 625,000.00
Dec 31, 2023 615,000.00
Sep 30, 2023 600,000.00
Jun 30, 2023 600,000.00
Mar 31, 2023 600,000.00
Dec 31, 2022 570,000.00
Sep 30, 2022 417,000.00
Jun 30, 2022 312,000.00
Mar 31, 2022 309,000.00
Dec 31, 2021 259,000.00
Sep 30, 2021 200,000.00
API Access

Tango Therapeutics Depreciation & Amortization (CF) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=TNGX&period=max&api_key=YOUR_API_KEY